ATP-competitive c-Jun N-terminal kinase (JNK) inhibitor (IC50
values are 2, 4 and 52 nM for JNK1, JNK2 and JNK3 respectively). Displays > 1000 fold selectivity over other kinases, including ERK2 and p38. Inhibits c-Jun phosphorylation (EC50
= 920 nM) and prevents collagen-induced platelet aggregation in vitro
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.
Szczepankiewicz et al.
Involvement of the mirogen-activated protein kinase c-Jun NH2-terminal kinase 1 in thrombus formation.
Kauskot et al.